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Respiratory complex II: Role in cellular physiology and diseaseThe family of respiratory proteins termed complex II is evolution-
arily conserved throughout both prokaryotes and eukaryotes. The
members of the family include the membrane bound protein com-
plexes succinate dehydrogenase (succinate-quinone reductase) and
fumarate reductase (quinol-fumarate reductase). In mitochondria
and many bacteria, complex II is an essential part of two metabolic
pathways, i.e., the citric acid cycle and the electron transport chain in-
volved in oxidative phosphorylation. The enzyme contains a number of
redox active centers including a covalently bound ﬂavin cofactor, three
distinct iron–sulfur clusters, a heme b, and a quinone-binding site.
Chemically, the oxidation of succinate at one of the two active sites of
the enzyme results in reduction of the covalently bound FAD cofactor,
the FADH2 generated is then reoxidized by coenzyme Q10 (ubiquinone)
at the second active site in the membrane domain of complex II. Thus,
these reactions couple the citric acid cycle with quinone reduction to
provide reducing equivalents to the respiratory chain as part of the
overall energy generating system of the cell. Fumarate reductase is
part of the anaerobic metabolism in many anaerobic and facultative
bacteria and lower eukaryotes where it catalyzes the reverse reaction,
i.e., quinol oxidation coupled with fumarate reduction. Both en-
zymes, however, can catalyze both succinate oxidation and fumarate
reduction although they are poised to be more efﬁcient in their pre-
ferred catalytic direction. These properties of the enzymemake com-
plex II an excellent model system for the study of a number of
different electron transfer reactions. The reversibility of the enzymes
may also contribute to the association of complex II with a number of
metabolic diseases which have become an area of intense investigation
following the advances of human genomic analysis in the 21st century.
In this Special Issue of BBA Bioenergetics, a variety of timely topics
related to complex II are reviewed. A particular focus is the relation of
complex II to mitochondria-associated diseases in humans. These ar-
ticles describe the diversity of human diseases affected by the mal-
function or assembly of complex II and also discuss a variety of
mechanisms by which dysfunction of the complex manifests itself in
human disease. Althoughmitochondria-associated diseases have prov-
en difﬁcult to treat, new anti-cancer drugs that target complex II and are
showing promise in treating speciﬁc types of tumors in animal and cel-
lular models are described in these articles. Many of these advances in
understanding the physiological consequences ofmutations in complex
II have been aided by analysis of X-ray crystal structures. The wealth of
information provided by the analysis of the architecture of complex II is
reviewed in this Special Issue providing insight into how mutations of
the enzyme complex contribute to alterations in catalytic activity
and reactive oxygen species formation. Structures are now available
from bacterial succinate dehydrogenase and fumarate reductase to
the succinate dehydrogenase from lower eukaryotes, as well as avian0005-2728/$ – see front matter © 2013 Published by Elsevier B.V.
http://dx.doi.org/10.1016/j.bbabio.2013.02.010and mammalian sources. These articles show that the high degree of
conservation of the overall structure of complex II should allow a num-
ber of useful models of complex II to be developed. As described in this
issue such models are needed to fully understand the effects of muta-
tions of nuclear encoded complex II subunits on mitochondrial physiol-
ogy. In addition, the structures aid in deﬁning discrete electron transfer
pathways in the enzymewhichwhen altered bymutationmay contrib-
ute to the dysfunction of complex II associated with mitochondrial
disease.
Although complex II is the smallest mitochondrial respiratory
complex in terms of number of subunits, it nevertheless utilizes a va-
riety of redox cofactors and therefore would seem to require addi-
tional factors to aid in its proper assembly. A previous Special Issue
of BBA Bioenergetics (1817, 2012) had discussed the biogenesis/
assembly of respiratory enzyme complexes describing the multiple
components needed for proper assembly of these molecular ma-
chines. As discussed in this Special Issue, complex II now joins the
other respiratory complexes where the need is shown for additional
protein factors required for proper assembly of the complex. Two ar-
ticles in the Special Issue describe how prokaryotes and eukaryotes
utilize additional small proteins for assembly of the redox centers of
complex II. These articles describe assembly factors which assist in
the attachment of the covalently bound ﬂavin and additional assem-
bly factors apparently needed for assembly of the iron–sulfur clusters
of the enzyme. There are also articles which focus on individual com-
plex II subunits, describing the unique roles such proteins may play in
aspects of mitochondrial physiology other than their structural/
catalytic roles as part of the intact complex II. For example, one of
the membrane anchor subunits of complex II may play a part in the
mitochondrial protein import machinery and also there is a discus-
sion of the potential role for the membrane domain of complex II in
the putative mitochondrial KATP channel.
Although the articles in this Special Issue do not cover all aspects
of complex II currently under active investigation, they do provide a
thorough overview of the central relationship complex II has to cellu-
lar physiology. They also show the usefulness of complex II as a trac-
table experimental model for study of electron transfer mechanisms.
Complex II remains a fascinating enzyme even after six decades of
intense biochemical and biophysical investigations. There is still
much to be learned about its assembly, catalytic mechanism, and its
contribution to mitochondria-associated disease.
It has been my pleasure to act as a guest editor for this Special
Issue on complex II. The enzyme has provided me with many exciting
insights into the molecular function of respiratory proteins, as well as
numerous puzzles which we are yet to understand. I expect that with
the modern advances in biophysical and “omic” sciences, we may
542 Prefacewell address these puzzles over the next decade. I certainly appreci-
ate the effort all of the contributing authors went to in preparing
their articles. I also want to thank the editorial staff of BBA Bioener-
getics, and in particular Sandra Tokashiki, whose help greatly eased
the preparation of this issue.
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